Skeletal Phenotyping Core

$390,042P30FY2014ARNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

Paper 39024412 Paper 38836497 Paper 38530370 Paper 37681409 Paper 36472957 Paper 35747128 Paper 35460406 Paper 35169297 Paper 34968192 Paper 34725346 Paper 34609896 Paper 34230488 Paper 34160349 Paper 34043707 Paper 33440155 Paper 33400836 Paper 33242090 Paper 33210065 Paper 33148508 Paper 33130337 Paper 32845528 Paper 32612176 Paper 32350260 Paper 32220312 Paper 31758181 Paper 31700184 Paper 31693237 Paper 31496241 Paper 31484825 Paper 31418572 Paper 31273195 Paper 31173907 Paper 31170511 Paper 31112135 Paper 31101754 Paper 31003999 Paper 30954729 Paper 30843886 Paper 30804514 Paper 30735895 Paper 30735122 Paper 30729461 Paper 30659979 Paper 30463736 Paper 30442659 Paper 30388100 Paper 30362896 Paper 30312418 Paper 30213970 Paper 30150661 Paper 30150136 Paper 30118980 Paper 30053608 Paper 30042178 Paper 29980569 Paper 29800694 Paper 29765356 Paper 29471062 Paper 29467330 Paper 29399440 Paper 29366838 Paper 29352303 Paper 29191879 Paper 29162742 Paper 29161432 Paper 29078380 Paper 29064243 Paper 29018244 Paper 28977604 Paper 28928248 Paper 28758904 Paper 28704395 Paper 28671685 Paper 28448530 Paper 28194446 Paper 28073913 Paper 27932380 Paper 27925290 Paper 27881824 Paper 27862326 Paper 27768111 Paper 27759007 Paper 27653320 Paper 27623705 Paper 27533344 Paper 27526034 Paper 27428040 Paper 27399886 Paper 27329220 Paper 27324177 Paper 27068606 Paper 26865415 Paper 26806052 Paper 26763740 Paper 26751835 Paper 26657770 Paper 26620087 Paper 26562265 Paper 26503464 Paper 26428657

Abstract

Identification of the structural, architectural, cellular and molecular basis for the skeletal phenotypes that result from genetic/pharmacologic interventions and disease states is essential for translating scientific discoveries into therapeutic innovations. The goal of the Skeletal Phenotyping Core is to provide costefficient, state ofthe art, quality-controlled skeletal phenotyping services to fulfill the unmet needs of junior investigators who are transitioning to an independent career in skeletal biology, of established investigators who are new to skeletal biology and of established skeletal biologists. A key part ofthe mission ofthe Skeletal Phenotyping Core will be education, mentoring and incorporation of novel and innovative services to meet the needs ofthe constituent investigators. Consultation regarding experimental design, specimen handling and data analysis will be provided by Core directors, to insure that the maximal amount of data can be obtained from each specimen/subject. The Core will host didactic teaching sessions, hands-on workshops and seminars designed to educate investigators and to foster collaboration among investigators. A special focus ofthe Core will be mentorship of junior investigators and of those investigators new to skeletal biology. This infrastructure and these activities will 1) enhance the productivity and expand the scope of research being conducted by the Core investigators, 2) promote innovation and incorporation of novel technologies into core services 3) foster synergy across a large and diverse community interested in skeletal research, ultimately leading to levels of success greater than the sum of the individual investigators' projected achievements. This will be achieved by the following specific Aims: Aim 1: Provide efficient, high-quality, state-of-the-art skeletal phenotyping services that are not readily supported by individual research grants; Aim 2: Provide shared resources, training, and educational services to support new investigators in skeletal biology and to facilitate collaboration among core investigators.

View original record on NIH RePORTER →